We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$180M
AUM Growth
-$16.6M
Cap. Flow
-$8.49M
Cap. Flow %
-4.71%
Top 10 Hldgs %
42.71%
Holding
128
New
34
Increased
5
Reduced
15
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 85.22%
2 Financials 3.64%
3 Technology 0.85%
4 Communication Services 0.51%
5 Materials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POL.WS
51
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$604K 0.34%
6,103,824
NVTA
52
DELISTED
Invitae Corporation
NVTA
$552K 0.31%
+409,200
New +$806K
BTM
53
DELISTED
Bitcoin Depot
BTM
$518K 0.29%
+7,143
New +$511K
OHAA
54
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$513K 0.28%
50,000
PSQH icon
55
PSQ Holdings
PSQH
$14.7M
$507K 0.28%
3,333
VRNA
56
DELISTED
Verona Pharma
VRNA
$502K 0.28%
25,000
-190,000
-88% -$4.1M
DDI
57
DoubleDown Interactive
DDI
$588M
$486K 0.27%
60,876
CSSE
58
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$424K 0.24%
+212,164
New +$999K
POL
59
DELISTED
Polished.com Inc.
POL
$300K 0.17%
11,521
-8,495
-42% -$269K
WLDSW icon
60
Wearable Devices Ltd Warrant
WLDSW
$194K 0.11%
1,961
PBLA
61
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$148K 0.08%
+559
New +$542K
DRCTW
62
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$135K 0.07%
180,000
NEXRW
63
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$106K 0.06%
980,770
+500,000
+104% +$78K
REVB icon
64
Revelation Biosciences
REVB
$4.46M
$48.4K 0.03%
+6
New +$162K
CINGW icon
65
Cingulate Inc Warrants
CINGW
$33.2K
$46.2K 0.03%
270,000
LUCYW icon
66
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$123K
$44.8K 0.02%
122,400
-27,600
-18% -$7.73K
BRSHW
67
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$43.3K 0.02%
360,579
PEPLW
68
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$34.9K 0.02%
367,500
NXGLW icon
69
NexGel Inc Warrant
NXGLW
$34.9K 0.02%
225,000
HCDIZ
70
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$32.4K 0.02%
650,000
NLSPW
71
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$30K 0.02%
200,000
ONFOW icon
72
Onfolio Holdings Warrant
ONFOW
$64.5K
$28.1K 0.02%
200,000
OSAAW
73
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$23.7K 0.01%
150,000
BNCWW
74
CEA Industries Inc Warrant
BNCWW
$19.8K 0.01%
250,000
ZEV.WS
75
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$16.6K 0.01%
652,173

Similar funds

Altium Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Altium Capital Management held 128 positions worth $180M, down 8.5% from $197M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Altium Capital Management withdrew a net $8.49M in Q1 2023, closing 37 positions and reducing 15 holdings. Its most notable exit was Akero Therapeutics, an estimated $6.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 89% a quarter earlier, followed by Financials and Technology.

Against the trend, Altium Capital Management opened a new position in Avadel Pharmaceuticals worth $4.58M.

  • Altium Capital Management's largest Q1 2023 buy was Avadel Pharmaceuticals: 500,000 shares worth $4.58M.
  • Altium Capital Management added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2023, an estimated $2.08M increase.
  • Altium Capital Management's biggest Q1 2023 reduction was PepperLime Health Acquisition Corporation Class A Ordinary Share, cutting an estimated $6.47M.
  • Altium Capital Management fully exited Akero Therapeutics in Q1 2023, selling an estimated $6.85M.
  • Altium Capital Management's ten largest holdings make up 43% of its $180M portfolio in Q1 2023.
  • Altium Capital Management opened 34 new positions and closed 37 in Q1 2023.
  • Altium Capital Management's portfolio value fell 8.5% quarter-over-quarter to $180M.

Based on Altium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.